Trevi Therapeutics, Inc. financial data

Symbol
TRVI on Nasdaq
Industry
Pharmaceutical Preparations
Location
195 Church Street, 14 Th Floor, New Haven, Connecticut
State of incorporation
Delaware
Fiscal year end
December 31
Latest financial report
Q1 2024 - May 7, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 1.7 K % +117%
Debt-to-equity 7.44 % -59.3%
Return On Equity -39.5 % -33%
Return On Assets -36.8 % -46.4%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 69 M shares +14.8%
Common Stock, Shares, Outstanding 69 M shares +14.8%
Entity Public Float 106 M USD +62%
Common Stock, Value, Issued 69 K USD +15%
Weighted Average Number of Shares Outstanding, Basic 99.5 M shares +0.92%
Weighted Average Number of Shares Outstanding, Diluted 99.5 M shares +0.92%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense 27.5 M USD +36.1%
General and Administrative Expense 10.8 M USD +5.1%
Operating Income (Loss) -38.3 M USD -25.7%
Nonoperating Income (Expense) 4.67 M USD +114%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -33.6 M USD -18.9%
Income Tax Expense (Benefit) -33 K USD +13.2%
Net Income (Loss) Attributable to Parent -33.6 M USD -18.9%
Earnings Per Share, Basic -0.34 USD/shares -25.9%
Earnings Per Share, Diluted -0.34 USD/shares -25.9%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 13.8 M USD +18.5%
Marketable Securities, Current 59 M USD -40.8%
Other Assets, Current 721 K USD -55.2%
Assets, Current 76.8 M USD -32.8%
Property, Plant and Equipment, Net 204 K USD -16.7%
Operating Lease, Right-of-Use Asset 1.08 M USD -16.1%
Other Assets, Noncurrent 311 K USD +38.2%
Assets 78.6 M USD -32.4%
Accounts Payable, Current 2.11 M USD +6.51%
Accrued Liabilities, Current 2.84 M USD -18.2%
Liabilities, Current 5.28 M USD -60%
Operating Lease, Liability, Noncurrent 949 K USD -17.3%
Other Liabilities, Noncurrent 3 K USD
Liabilities 6.23 M USD -57%
Accumulated Other Comprehensive Income (Loss), Net of Tax -67 K USD +23.9%
Retained Earnings (Accumulated Deficit) -250 M USD -15.5%
Stockholders' Equity Attributable to Parent 72.3 M USD -28.9%
Liabilities and Equity 78.6 M USD -32.4%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -10.5 M USD -27.7%
Net Cash Provided by (Used in) Financing Activities -28 K USD +98.4%
Net Cash Provided by (Used in) Investing Activities -8.09 M USD -190%
Common Stock, Shares Authorized 200 M shares 0%
Common Stock, Shares, Issued 69 M shares +14.8%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -18.6 M USD -1881%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 13.8 M USD +18.5%
Interest Paid, Excluding Capitalized Interest, Operating Activities 331 K USD -44.3%
Deferred Tax Assets, Valuation Allowance 69.5 M USD +13.8%
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent 0.21 pure 0%
Deferred Tax Assets, Gross 70.1 M USD +14.3%
Operating Lease, Liability 1.15 M USD -11.2%
Depreciation 81 K USD +88.4%
Payments to Acquire Property, Plant, and Equipment 137 K USD -13.8%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -33.5 M USD -18.5%
Lessee, Operating Lease, Liability, to be Paid 1.42 M USD -16.3%
Property, Plant and Equipment, Gross 350 K USD -11.4%
Operating Lease, Liability, Current 198 K USD +37.5%
Lessee, Operating Lease, Liability, to be Paid, Year Two 368 K USD +5.44%
Lessee, Operating Lease, Liability, to be Paid, Year One 349 K USD +15.2%
Operating Lease, Weighted Average Discount Rate, Percent 0.11 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 276 K USD -32.4%
Lessee, Operating Lease, Liability, to be Paid, Year Three 377 K USD +2.45%
Deferred Tax Assets, Operating Loss Carryforwards 50.3 M USD +4.74%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 5 M shares 0%
Lessee, Operating Lease, Liability, to be Paid, Year Four 95 K USD -74.8%
Operating Lease, Payments 276 K USD +132%
Additional Paid in Capital 322 M USD +1.3%
Preferred Stock, Shares Outstanding 0 shares
Current State and Local Tax Expense (Benefit) -32 K USD +11.1%
Depreciation, Depletion and Amortization 35 K USD +84.2%
Interest Expense 161 K USD -85.3%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%